Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Antonio Fernandez-Nebro

Profesor titular acreditado como catedrático (Reader)

University of Malaga

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID Google Scholar

Research Interests

Immunology

50%

Internal Medicine

30%

Rheumatology

80%

Inflammatory Disease

50%

Autoinflammatory Disease

50%

Inflammatory Biology

40%

Pulmonary Fibrosis

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles22

Longitudinal Assessment of Body Composition and Inflammatory Status in Rheumatoid Arthritis During TNF Inhibitor Treatment: A Pilot Study

Article Link

Year:

2025

Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort

Article Link

Year:

2025

EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritis

Article Link

Year:

2025

Accrual of organ damage and one-year mortality in systemic sclerosis: A prospective observational study

Article Link

Year:

2025

Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

Article Link

Year:

2025

DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case–control study

Article Link

Year:

2025

Identifying inflammatory phenotypes associated with lung involvement in systemic sclerosis: k-means clustering approach

Article Link

Year:

2025

Impact of TNF inhibitors on inflammation-associated cognitive dysfunction in patients with rheumatoid arthritis: a prospective analysis

Article Link

Year:

2025

Intestinal Dysbiosis, Tight Junction Proteins, and Inflammation in Rheumatoid Arthritis Patients: A Cross-Sectional Study

Article Link

Year:

2024

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

Article Link

Year:

2024

Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: A longitudinal analysis

Article Link

Year:

2024

Prevalence of Malnutrition and Associated Factors in Older Patients with Rheumatoid Arthritis: A Cross-Sectional Study

Article Link

Year:

2023

Sarcopenia and Nutrition in Elderly Rheumatoid Arthritis Patients: A Cross-Sectional Study to Determine Prevalence and Risk Factors

Article Link

Year:

2023

Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis–Associated Interstitial Lung Disease

Article Link

Year:

2023

Interstitial Lung Disease Is Associated with Sleep Disorders in Rheumatoid Arthritis Patients

Article Link

Year:

2023

miRNA-Mediated Epigenetic Regulation of Treatment Response in RA Patients—A Systematic Review

Article Link

Year:

2022

Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

Article Link

Year:

2022

Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease

Article Link

Year:

2022

Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

Article Link

Year:

2022

Importance of Vaccination against SARS-CoV-2 in Patients with Interstitial Lung Disease Associated with Systemic Autoimmune Disease

Article Link

Year:

2022

Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study

Article Link

Year:

2022

Postprandial Hyperlipidemia: Association with Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

Article Link

Year:

2022

Collaborators8

José Manuel Lisbona

Instituto de Investigación Biomédica de Málaga

SPAIN

Antonio Julià Cano

Lab head

Vall d'Hebron Institut de Recerca

SPAIN

Francisco J. Blanco-García

Universidade da Coruña

SPAIN

Paloma Vela Casasempere

Instituto de Investigación Sanitaria y Biomédica de Alicante

SPAIN

CHARY LOPEZ-PEDRERA

Head of Research

SPAIN

Desiree Ruiz Vilchez

Instituto Maimónides de Investigación Biomédica de Córdoba

SPAIN

Javier Narvaez

Profesor Titular de Medicina

University of Barcelona

SPAIN

Sara Manrique-Arija

Associate Lecturer

Universidad de Málaga Facultad de Medicina

SPAIN

How do I reach out?

Meet Kite AI

Antonio Fernandez-Nebro

Profesor titular acreditado como catedrático (Reader)

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles22

Longitudinal Assessment of Body Composition and Inflammatory Status in Rheumatoid Arthritis During TNF Inhibitor Treatment: A Pilot Study

Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort

EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritis

Accrual of organ damage and one-year mortality in systemic sclerosis: A prospective observational study

Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case–control study

Identifying inflammatory phenotypes associated with lung involvement in systemic sclerosis: k-means clustering approach

Impact of TNF inhibitors on inflammation-associated cognitive dysfunction in patients with rheumatoid arthritis: a prospective analysis

Intestinal Dysbiosis, Tight Junction Proteins, and Inflammation in Rheumatoid Arthritis Patients: A Cross-Sectional Study

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: A longitudinal analysis

Prevalence of Malnutrition and Associated Factors in Older Patients with Rheumatoid Arthritis: A Cross-Sectional Study

Sarcopenia and Nutrition in Elderly Rheumatoid Arthritis Patients: A Cross-Sectional Study to Determine Prevalence and Risk Factors

Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis–Associated Interstitial Lung Disease

Interstitial Lung Disease Is Associated with Sleep Disorders in Rheumatoid Arthritis Patients

miRNA-Mediated Epigenetic Regulation of Treatment Response in RA Patients—A Systematic Review

Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease

Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

Importance of Vaccination against SARS-CoV-2 in Patients with Interstitial Lung Disease Associated with Systemic Autoimmune Disease

Efficacy and Safety of Rituximab in Autoimmune Disease&mdash;Associated Interstitial Lung Disease: A Prospective Cohort Study

Postprandial Hyperlipidemia: Association with Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

Collaborators8

José Manuel Lisbona

Antonio Julià Cano

Francisco J. Blanco-García

Paloma Vela Casasempere

CHARY LOPEZ-PEDRERA

Desiree Ruiz Vilchez

Javier Narvaez

Sara Manrique-Arija

How do I reach out?

Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study